Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 600-605

  Tseng, Leon F ^a   Narita, Minoru ^a   Mizoguchi, Hirokazu ^a   Kawai, Kohji ^b   Mizusuna, Akira ^b   Kamei, Junzo ^c   Suzuki, Tsutomu ^c   Nagase, Hiroshi ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b TORAY INDUSTRIES INC   (Japan)

^c HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; NALTRIBEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG RECEPTOR BINDING; ENANTIOMER; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; SPINAL CORD; TAIL FLICK TEST;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANIMALS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; HYPERALGESIA; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED ICR; PAIN; PAIN MEASUREMENT; PYRROLIDINES; QUINOLINES; REACTION TIME; RECEPTORS, OPIOID, DELTA; SPINAL CORD;

EID: 0030974946     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. 4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor. Life Sci. 55: PL37-PL43, 1994.
2. D'AMOUR, F. E. AND SMITH, D. L.: A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72: 74-79, 1941.
3. EVANS, C. J., KEITH, D. E., MORRISON, H., MAGENDOZO, K. AND EDWARDS, R. H.: Cloning of a δ-opioid receptor by functional expression. Science 258: 1952-1955, 1992.
4. 2 (CTOP) in mice. Eur. J. Pharmacol. 150: 355-360, 1988.
5. HYLDEN, J. L. K. AND WILCOX, G. L.: Intrathecal morphine in mice: A new technique. Eur. J. Pharmacol. 67: 313-316, 1980.
6. KAMEI, J., SAITOH, A., OHSAWA, M., SUZUKI, T., MISAWA, M., NAGASE, H. AND KASUYA, Y.: Antinociceptive effects of the selective non-peptidic δ-opioid receptor agonist TAN-67 in diabetic mice. Eur. J. Pharmacol. 276: 131-135, 1995.
7. KIEFFER, B., BEFORT, K., GARERIAUZ-RUFF, C. AND HIRTH, C.: The delta-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U.S.A. 89: 12048-12052, 1992.
8. KNAPP, R. J., LANDSMAN, R., WAITE, S., MALATYNSKA, E., VARGA, E., HAQ, W., HRUBY, V. J., ROESKE, W. R., NAGASE, H. AND YAMAMURA, H.: Properties of TAN-67, a nonpeptidic δ-opioid receptor agonist, at cloned human δ- and μ-opioid receptors. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 291: 129-134, 1995.
9. 2-agonist antinociception. NeuroReport 5: 1049-1052, 1994.
10. MIZOGUCHI, H., NARITA, M., NAGASE, H. AND TSENG, L. F.: Antisense oligodeoxynucleotide to a δ-opioid receptor blocks the antinociception induced by cold water swimming. Regul. Pept. 59: 255-259, 1955.
11. NAGASE, H., WAKITA, H., KAWAI, K., ENDOH, T., MATSURA, H., TANAKA, C. AND TAKEZAWA, Y.: Syntheses of non-peptiditic delta opiodi receptor agonists and their structure activity relationships. Jpn. J. Pharmacol. 64: suppl. 1, 35, 1994.
12. NAGASE, H., WAKITA, H., KAWAI, K., MIZUSUNA, A., ENDO, T., MATSUURA, H., TAJIMA, C., TAKEZAWA, Y., NARITA, M., MIZOGUCHI, H. AND TSENG, L. F.: Drug design of highly selective non-peptide opioid delta agonists, and their pharmacolgy. Jpn. J. Pharmacol. 71: suppl. 9p, 1996.
13. NARITA, M., MIZOGUCHI, H., KAMPINE, J. P. AND TSENG, L. F.: Role of protein kinase C in desensitization of spinal δ-opioid-mediated antinociception in the mouse. Br. J. Pharmacol. 118: 1829-1835, 1996.
14. PORTOGHESE, P. S.: An approach to the design of receptor-type-selective nonpeptide antagonists of peptidergic receptors; δ opioid antagonists. J. Med. Chem. 34: 1757-1762, 1991.
15. 1opioid receptor antagoists: 7-benzylidene naltrexone. Eur. J. Pharmacol. 218: 195-196, 1992.
16. SOFUOGLU, M., PORTOGHESE, P. S. AND TAKEMORI, A. E.: Differential antagonism of delta opioid antagonists by naltrindole and its benzofuran analog (naltriben) in mice: Evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther. 257: 676-680, 1991.
17. SPANAGEL, R., ALMEIDA, O. F. X. AND SHIPPENBERG, T. S.: Evidence that norbinaltorphimine can function as an antagonist at multiple opioid receptor subtypes. Eur. J. Pharmacol. 264: 157-162, 1994.
18. 4]deltorphin. J. Pharmacol. Exp. Ther. 266: 820-828, 1994.
19. SUZUKI, T., TSUJI, M., MORI, T., MISAWA, M., ENDOH, T. AND NAGASE, H.: Effects of highly selective nonpeptidic δ opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice. Life Sci. 57: 155-168, 1995.
20. TAKEMORI, A. E., HO, B. Y., NAESETH, J. S. AND PORTOGHESE, P. S.: Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther. 246: 255-258, 1988.
21. TALLARIDA, R. I. AND MURRAY, R. B.: Manual of Pharmacologic Calculation with Computer Program, Sporograms, Springer-Verlag, New York, 1987
22. TSENG, L. F., COLLINS, K. A. AND KAMPINE, J. P.: Antisense oligodeoxynucleotide to a δ-opioid receptor selectively blocks the spinal antinociception induced by δ-, but not μ- or κ-opioid receptor agonists in the mouse. Eur. J. Pharmacol. 258: R1-R3, 1994.
23. 1-opioid receptors are involved in intracerebroventricular β-endorphin-induced antinociception in the mouse. Life Sci. 52: PL 211-215, 1993.
24. 1-, μ-, or κ-opioid receptors are involved in the tail-flick inhibition by β-endorphin from nucleus raphe obscurus in the pentobarbital-anesthetized rat. Eur. J. Pharmacol. 277: 251-256, 1995.